Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus - Top-Institutions - MDSpire

Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus

  • By

  • Borja del Carmelo Gracia Tello

  • José Miguel García-Bruñén

  • Luis Corredor

  • Natalia Allue Fantova

  • Eva Ma Calvo Beguería

  • Rubén García-Muñío

  • Laura Pérez Abad

  • Jimena Aramburu Llorente

  • Beatriz Martinez Muriel

  • Paula Vidales Miguélez

  • Roxanna Alexandra Morante Mendoza

  • Julia Martínez Artigot

  • Noelia Chicano Nieto

  • Jorge Álvarez Troncoso

  • Luis Martinez-Lostao

  • Adela Marín Ballvé

  • May 8, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    University Clinic Hospital Lozano Blesa
    University Clinic Hospital Lozano Blesa

    Zaragoza, Aragon

    Key Differentiators

    • Rheumatology

  • #2

    Ruijin Hospital
    Ruijin Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Rheumatology

  • #3

    Nanjing Drum Tower Hospital
    Nanjing Drum Tower Hospital

    Nanjing, Jiangsu

    Key Differentiators

    • Rheumatology

  • #4

    Wuhan No.1 Hospital
    Wuhan No.1 Hospital

    Wuhan, Hubei

    Key Differentiators

    • Rheumatology

Original Source(s)

Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus

  • by Borja del Carmelo Gracia Tello, José Miguel García-Bruñén, Luis Corredor, Natalia Allue Fantova, Eva Ma Calvo Beguería, Rubén García-Muñío, Laura Pérez Abad, Jimena Aramburu Llorente, Beatriz Martinez Muriel, Paula Vidales Miguélez, Roxanna Alexandra Morante Mendoza, Julia Martínez Artigot, Noelia Chicano Nieto, Jorge Álvarez Troncoso, Luis Martinez-Lostao, Adela Marín Ballvé

  • May 8, 2026

Related Content

AAO Updates HCQ Retinopathy Guidance

Updated recommendations emphasize dosing limits and screening for toxicity risk.

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

Can RAIL Predict Lupus Nephritis Course?

Urine biomarker index was associated with kidney inflammation and future treatment response across visits.